CIRRHOSIS
Clinical trials for CIRRHOSIS explained in plain language.
Never miss a new study
Get alerted when new CIRRHOSIS trials appear
Sign up with your email to follow new studies for CIRRHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could home devices keep cirrhosis patients out of the hospital?
Disease control TerminatedThis study tested whether sending recently discharged cirrhosis patients home with monitoring devices could help keep them healthier and reduce return trips to the hospital. About 120 patients were randomly assigned to either use the home monitoring kit or receive standard follow…
Matched conditions: CIRRHOSIS
Phase: EARLY_PHASE1 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Drug trial aims to stop deadly bleeding in scarred livers
Prevention TerminatedThis study tested whether a drug called belapectin could prevent the development of esophageal varices—dangerous, swollen veins in the esophagus—in people with advanced liver scarring (cirrhosis) caused by NASH. It involved 357 adults who had cirrhosis but did not yet have these …
Matched conditions: CIRRHOSIS
Phase: PHASE2, PHASE3 • Sponsor: Galectin Therapeutics Inc. • Aim: Prevention
Last updated Mar 20, 2026 14:48 UTC
-
Researchers test strength and balance to predict liver transplant success
Knowledge-focused TerminatedThis study aimed to understand how physical weakness and frailty affect people with severe liver disease before and after liver transplant. Researchers measured 411 patients' strength, walking speed, balance, and daily activity abilities to see if these tests could predict recove…
Matched conditions: CIRRHOSIS
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC